Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors
Authors:
Open Access
- 28 August 2015
- journal article
- research article
- Published by Springer Nature in SpringerPlus
- Vol. 4 (1) , 459
Abstract
As the breast cancer survivor population increases, the topic of screening these women for recurrences is increasingly relevant. In our institution, we use both breast MRI and mammography in the surveillance of breast cancer survivors, although little data exists on the use of MRI in this setting. We present a retrospective analysis of our experience and compare the sensitivity and specificity of MRI vs. mammography in this setting. We identified women under 65 with a history of breast cancer and at least one follow-up MRI performed along with a mammogram done within 6 months of the MRI. We compared the outcomes of MRI and mammography in terms of biopsies performed as well as in detection of new cancers. Of 617 charts reviewed, 249 patients met inclusion criteria, with 571 paired MRI/mammogram results. There were 27 biopsies performed due to MRI findings alone, 10 done due to mammographic findings alone, and 15 done based on abnormalities seen on both imaging modalities. There were 8 malignancies identified based on an abnormal MRI, 3 detected on both MRI and mammography, and none identified via mammography alone. Overall, MRI had a sensitivity of 84.6% (the 95% CI 54.6–98.1) and a specificity of 95.3% (the 95% CI 93.3–96.9); mammography a sensitivity of 23.1% (the 95% CI 5.0–53.8), and a specificity of 96.4% (the 95% CI 94.5–97.8). Breast MRI is a useful surveillance modality in breast cancer survivors and may be more sensitive at detecting recurrences than mammography alone in this population.Keywords
This publication has 37 references indexed in Scilit:
- Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2013
- Outcomes of Surveillance for Contralateral Breast Cancer in Patients Less than Age 60 at the Time of Initial DiagnosisCurrent Oncology, 2012
- A Canadian Perspective on Bendamustine for the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin LymphomaCurrent Oncology, 2012
- Long-term results of screening with magnetic resonance imaging in women with BRCA mutationsBritish Journal of Cancer, 2012
- Declining Incidence of Contralateral Breast Cancer in the United States From 1975 to 2006Journal of Clinical Oncology, 2011
- African ancestry and higher prevalence of triple‐negative breast cancerCancer, 2010
- Early detection of second breast cancers improves prognosis in breast cancer survivorsAnnals of Oncology, 2009
- Racial and ethnic differences in breast cancer survivalCancer, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Expert heads a'rollingThe Lancet, 2005